Resource Centers
- American Society for Bone and Mineral Research (ASBMR) 30th Annual Meeting
September 12 - 16, 2008, Montreal, Quebec, Canada
- Pfizer to Drop Development of Drugs for Hyperlipidemia, Atherosclerosis, and Heart Failure
- Merck Stops Taranabant Development: Will Not Seek FDA Approval
- Gene Variants Influence Effectiveness of Weight Loss Drug
- Recalls & Warnings FDA Finds No Link Between Statin Use and ALS
- New Study Finds Type of HRT Is Key With Regard to MI Risk
- Cognitive Function May Remain Stable in Teens With Type 1 Diabetes
Diabetes & Endocrinology Journals
- Glycemic Control for the Kidney, by the Kidney: Exploring the Role of SGLT2 Inhibition in Type 2 Diabetes Mellitus
- The Role of Incretin Therapy for Type 2 Diabetes in Family Medicine
- Pituitary Apoplexy Within a Macroprolactinoma
- Two-Year Pulmonary Safety and Efficacy of Inhaled Human Insulin (Exubera) in Adult Patients With Type 2 Diabetes
Medscape Community Resources
- Coffee -- The Good, the Bad, and the We Don't Know Yet
- Insulin and Visually Impaired Patients
- Use of Combination ACE Inhibitors and ARB Therapy in Patients With Chronic Kidney Disease
- The Benefits of Continuous Glucose Monitoring
- Insulin Therapy in Type 2 Diabetes: Primary Care Challenges and Solutions
POLL
The office of the US surgeon general recently issued a call to action to prevent deep vein thrombosis and pulmonary embolism. How effective do you think such public health campaigns are in reducing disease incidence?
Expert Video Blogs
Diabetes & Endocrinology CME
- The Astute Clinician: Filing High-Value Adverse Drug Event Reports
- Communicating Drug Risks to Patients
- Management of Dyslipidemia in a Patient With Type 2 Diabetes
- The Evolution of the Diagnosis and Management of Painful Diabetic Peripheral Neuropathy
- Are We Providing State-of-the-Art Care for Girls and Women with Turner Syndrome?
Advisory Board
Editorial Director
